other material
confidence high
sentiment neutral
materiality 0.65
GRI Bio expands ATM equity offering capacity from $10M to $60M via H.C. Wainwright amendment
GRI Bio, Inc.
- Amendment to At The Market Offering Agreement increases aggregate offering price to $60 million.
- Prior cap was $10 million; amended agreement effective January 28, 2026.
- Waivers obtained from December 2025 Securities Purchase Agreement investor to permit ATM issuances.
- Prospectus supplement filed Jan 29, 2026 to register up to $60M of common stock.
- Sales agent remains H.C. Wainwright & Co., LLC; shares sold at market prices.